Clinical Trials Logo

Clinical Trial Summary

Due to genetic polymorphism about 15%-30% of the world population have low levels of MBL (Mannose Binding Lectin) in serum (below 500ng/mL). Different studies reported correlation between polymorphism in the MBL gene with low levels of MBL in serum and higher frequency of recurrent infections, severity of sepsis, ARDS and other infections. Urinary Tract Infection (UTI) is one of the very common infection in women. Since MBL is part of the innate immunity and there are proofs of relation between patients with recurrent infections and lack of MBL, we decided to explore a possible relation between low levels of MBL and different genotypes of MBL in young women and the risk to develop recurrent UTI.


Clinical Trial Description

n/a


Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT00678028
Study type Observational
Source HaEmek Medical Center, Israel
Contact
Status Completed
Phase N/A
Start date February 2008

See also
  Status Clinical Trial Phase
Recruiting NCT02246270 - Recurrent Urinary Tract Infections and Heparin (RUTIH Trial) Phase 1/Phase 2
Completed NCT01663181 - Pain-perception During Outpatient cystoscopy-a Prospective Controlled Study
Not yet recruiting NCT05402319 - Comparison of Three Different Antibiotic Treatments Against Recurrent Urinary Tract Infections in Catheterized Patients N/A
Recruiting NCT04846803 - Bacterial Interference for Preventing Recurrent Urinary Tract Infection - New Ways of Treatment N/A
Completed NCT02869165 - Vaginal and Urinary Microbiome Trial Phase 4
Recruiting NCT02016118 - Retrospective Analysis of Ialuril vs. Standard of Care in Recurrent Urinary Tract Infections N/A
Completed NCT03790254 - D Mannose for Prevention and Treatment of RUTIs
Recruiting NCT02490046 - D-mannose for the Prevention of UTIs in Multiple Sclerosis Phase 1